跳至主要内容
临床试验/NCT03650101
NCT03650101进行中(未招募)不适用

Improving Infant Hydrocephalus Outcomes in Uganda: Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure After ETV/CPC

Boston Children's Hospital3 个研究点 分布在 3 个国家目标入组 400 人开始时间: 2021年5月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
400
试验地点
3
主要终点
Bayley Scales of Infant Development, Third Edition (BSID-3), cognitive scaled score

研究概览

简要总结

Neonatal postinfectious hydrocephalus (PIH) is a major public health problem in East Africa.The standard treatment has long been placement of a ventriculoperitoneal shunt (VPS) but these devices require life-long maintenance and nearly all fail multiple times. Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC) is an alternate treatment to give patients a shunt-free life. In this study, the investigators aim to optimize the metrics of evaluation as quantitative prognostic indicators of treatment response and long term outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 180 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Infants less than 180 days (six months) old
  • Symptomatic hydrocephalus characterized by abnormal rate of head growth, full anterior fontanel, ventriculomegaly
  • A parent or a guardian qualified by Ugandan law to give informed consent
  • Patients from Eastern, Central and Northern districts of Uganda, and in geographic proximity to CURE hospital will be eligible

排除标准

  • Age greater than six months
  • No evidence of progressive hydrocephalus
  • Patients outside of the districts specified in the inclusion criteria

研究组 & 干预措施

Hydrocephalus group

Inclusion criteria:

  1. Age less than six months
  2. Symptomatic hydrocephalus characterized by abnormal rate of head growth, full anterior fontanel, ventriculomegaly
  3. A parent or a guardian qualified by Ugandan law to give informed consent
  4. Patients from Eastern, Central and Northern districts of Uganda, and in geographic proximity to CURE hospital will be eligible

Exclusion criteria:

  1. Age greater than six months
  2. No evidence of progressive hydrocephalus
  3. Patients outside of the districts specified in the inclusion criteria

干预措施: ETV/CPC (Procedure)

Control group

Inclusion criteria:

  1. Born at GA ≥ 37 weeks
  2. Age less than six months at the time of enrollment
  3. No known medical conditions
  4. With a parent or a guardian qualified by Ugandan law to give informed consent
  5. Parents live in one of the villages in the Mbale or Budaka District, in geographic proximity to CCHU.

Exclusion criteria:

  1. Born at GA < 37 weeks
  2. Age greater than six months
  3. Evidence of one or more medical conditions
  4. Living outside of the districts specified in the inclusion criteria.

结局指标

主要结局

Bayley Scales of Infant Development, Third Edition (BSID-3), cognitive scaled score

时间窗: 24 months of age

Scores on the BSID-3, which is used to evaluate infants and toddlers 1 to 42 months of age, range from 1 to 19, with higher scores indicating better performance; the mean (±standard deviation(SD)) score in the general population is 10±3.

Incidence of ETV/CPC treatment failure

时间窗: 6 months post-treatment

Treatment failure or success will be determined with the use of clinical and radiographic criteria. * Treatment success will be determined as the shift in the growth of head circumference to a normal rate, as plotted on a standard growth chart; decompression of the anterior fontanel; relief of symptoms of elevated intracranial pressure, such as irritability and vomiting; resolution of down-gaze or sixth cranial nerve palsy; and a decrease or arrest in ventriculomegaly as determined on Computerized Tomography (CT). * Treatment failure will be defined as treatment-related death or the need for a second operation for infection or for the recurrence of hydrocephalus.

次要结局

  • brain volume(pre-, 6, 12 months post-treatment and 24 months of age)
  • Cerebral oxygen metabolism(pre- and post-, 6, 12 months post-treatment and 24 months of age)
  • Bayley Scales of Infant Development, Third Edition (BSID-3), cognitive scaled score at 12 months post-treatment(12 months post-treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pei-Yi Lin

Assistant Professor

Boston Children's Hospital

研究点 (3)

Loading locations...

相似试验